After decades of pioneering work, our revolutionary platform launched. With our platform, scientists have the ability to precisely deposit epigenetic changes in a locus-specific manner, enabling manipulation of cell phenotype for therapeutic purpose.
Epigenic Therapeutics Announces $32 Million in Series A Funding to Bring Breakthrough Epigenome Medicine to Clinical Development
Along with your contribution, we are committed to benefiting patients with wide variety